Latest News & Features
Americas
The US Food and Drug Administration’s Oncologic Drugs Advisory Committee has recommended approval of the first biosimilar version of trastuzumab, a breast cancer-fighting monoclonal antibody. 14 July 2017
Americas
Medical device company Alps South has filed a complaint against its former law firm Shumaker, Loop & Kendrick for legal malpractice. 14 July 2017
Big Pharma
The Federal Court of Justice, Germany’s Supreme Court, has upheld a lower court’s ruling that granted a preliminary compulsory licence to use a patent protecting an HIV treatment. 13 July 2017
Americas
A collaboration between Bill Gates and Intellectual Ventures , in partnership with conglomerate GE, has signed a licensing deal with US diagnostics technology company Access Bio to make and sell tools for “rapidly” identifying asymptomatic malaria. 13 July 2017
Big Pharma
The UK Supreme Court has reformulated the three questions that should be asked when testing for equivalent patent infringement. 12 July 2017
Americas
The patent system in the US and the EU is not rewarding complex research into treatments for a host of prevalent diseases and conditions, and reforms are going in the wrong direction, says Erika Lietzan of the University of Missouri School of Law. 12 July 2017
Big Pharma
Precision medicine has come a long way since the completion of the Human Genome Project in 2003, but how have IP regimes developed in this area, asks Sheena Linehan of Potter Clarkson. 12 July 2017
Big Pharma
The Italian Patent and Trademark Office’s Board of Appeal has ruled that there are no rules preventing the office from adjudicating requests to limit the term of supplementary protection certificates. 12 July 2017
Biotechnology
The European Patent Office has reopened cases in which the decision depends entirely on the patentability of plants or animals obtained by an essentially biological process. 11 July 2017
Americas
The Broad Institute of MIT and Harvard has announced that it has entered talks to create a worldwide licensing pool for CRISPR/Cas9 patents. 11 July 2017